Quality Measures

AHA's comments on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system (PPS) proposed rule for fiscal year (FY) 2022.
The Food and Drug Administration approved Biogen’s Aduhelm to treat Alzheimer’s disease, the first new treatment approved for the disease since 2003.
The Centers for Medicare & Medicaid Services issued a proposed rule to update skilled nursing facility payment rates for fiscal year 2022.
The Centers for Medicare & Medicaid Services last month extended to April 1 the deadline for eligible hospitals to submit calendar year 2020 electronic clinical quality measures to the Hospital Inpatient Quality Reporting Program and Medicare Promoting Interoperability Program.
Starting today, hospitals can see the data that will be publicly reported on the Centers for Medicare & Medicaid Services (CMS) Care Compare website in April.
The National Quality Forum’s Measure Applications Partnership recently initiated its statutorily required annual review of the quality measures that the Centers for Medicare & Medicaid Services is considering for use in federal programs.
The Centers for Medicare & Medicaid Services announced that it is extending the third quarter 2020 data submission deadlines for several of its quality reporting and value programs for hospitals, post-acute care and other providers.
The Centers for Medicare & Medicaid Services on Dec. 1 will retire Hospital Compare and seven other health care quality compare websites, whose content has been transitioning since September to a single website called Care Compare.